Neurology Markets for Transdermal Patches


Chart_Collage_160   Published  October 2017 •  Catalog no. TCS912F  •  Price US $2,850



Unlike several other disease segments, progress toward curative medicine for neurological and related central nervous system disorders has remained elusive. The result is a therapeutic segment that relies heavily on control of symptoms and palliative care. These trends include the growing incidence of neurological disorders associated with longevity and aging, and significant increases in the number of children diagnosed with autism. Because diseases of the central nervous system often result in compromised cognitive and/or motor skills that can increase the level of involuntary non-compliance with therapeutic protocols, transdermal delivery of drugs targeting CNS disorders is generally viewed as a method that can increase patient safety and improve outcomes. In addition to the handful of FDA-approved transdermal CNS products, more than a dozen companies are currently pursuing a range of APIs in transdermal delivery systems that target neurological and CNS conditions. While none of these development-stage candidates is curative, the benefits they can offer in terms of patient ease-of-use, product safety and overall quality-of-care are expected to result in reduced morbidity and more effective symptom management for afflicted patients

Bar_Graph Transdermal Neurology Patches Report Brochure (Download PDF)

Blue document Transdermal Neurology Patches Report Order Form (Download PDF)


Neurology Markets for Transdermal Patches  – What You Will Learn

  • Analyzes and evaluates the global market opportunity for transdermal neurology prescription therapeutics and assesses the probable impact of evolving regulatory, economic and demand factors
  • Assesses transdermal products approved or in development for the delivery of therapeutic neurology drugs
  • Provides detailed descriptions of neurology treatment segments, market factors, and business strategies
  • Forecasts transdermal neurology drug product demand to 2022 by geographic region and product segment
  • Profiles sector companies, their product development activities, supply chain partners, business strategies, and collaboration partners
  • Evaluates the impact of economic, technology, and regulatory factors on CNS therapeutics demand

Neurology Markets for Transdermal Patches – Summary of Contents

 

Executive Summary

 

The Current CNS Drug Therapeutics Market

Unmet Needs in CNS Disease Treatment

The Opportunity for Transdermal Delivery of CNS Therapeutics

 

The CNS Therapeutics Market Opportunity

Changes and Trends in Incidence and Morbidity

The Demand Picture for CNS Therapeutics

Competitive Landscape

Factors Limiting Growth

 

Transdermal Drug Delivery to the CNS

Patch Designs and Construction

Transdermal Patch Manufacturing and Packaging

The Patch Manufacturing Ecosystem

CNS Patch Economics

Passive vs Active Delivery Systems

 

The Global Market for Transdermal CNS Therapeutics –Disease Segment Analysis

ADHD

Alzheimer’s Disease

Dementia

Depression

Migraine

Nausea

Parkinson’s Disease

Restless Leg Syndrome

Schizophrenia

 

Transdermal CNS Drug Product Analysis and Market Assessments

FDA Approved Transdermal CNS Prescription Products

MAO Inhibitors

Cholinergic Agents

Dopamine Agonists

CNS Stimulants

5-HT3 Receptor Antagonists

Non-FDA Approved Commercial Transdermal CNS Products

Non-U.S. Regional Product Assessment & Market Impact

Strategic Factors and Branding Issues

Development-Stage Transdermal CNS Prescription Products

AChE Inhibitors

Cholinergic Agents

Dopamine Agonists

5-HT3 Receptor Antagonists

Serotonin Agonists

Other Drug Classes

 

Transdermal CNS Therapeutics Market Data & Forecasts

 

Market Factors

Regulations and Approvals

Clinical Trials

Indications Prescribing Guidelines and Off-Label Prescribing

Rx-to-OTC Switching

Skin Patch Revenue Models

 

Market Participant Profiles